Technology
Health
Biotechnology

Applied Therapeutics

$9.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.64 (7.19%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell APLT and other stocks, options, ETFs, and crypto commission-free!

About APLT

Applied Therapeutics, Inc. Common Stock, also called Applied Therapeutics, is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. Read More The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Employees
Headquarters
New York, New York
Founded
2016
Market Cap
162.68M
Price-Earnings Ratio
Dividend Yield
Average Volume
9.60K
High Today
$9.75
Low Today
$8.75
Open Price
$8.97
Volume
6.74K
52 Week High
$11.20
52 Week Low
$7.95

Collections

Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Pharmaceutical
2019 IPO

APLT Earnings

-$0.72
-$0.64
-$0.56
-$0.48
Q2 2019
Estimated
Actual
-$0.60 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.